BIOMAT Database Logo BIOMAT Database Logo

Transition state analogue inhibitors of protozoan nucleoside hydrolases. 1999

R H Furneaux, and V L Schramm, and P C Tyler
Carbohydrate Chemistry, Industrial Research Limited, Lower Hutt, New Zealand.

Protozoan parasites are unable to synthesize purines de novo and must rely on purine salvage pathways for their requirements. Nucleoside hydrolases, which are not found in mammals, function as key enzymes in purine salvage in protozoa. Inhibition of these enzymes may disrupt purine supply and specific inhibitors are potential therapeutic agents for the control of protozoan infections. A series of 1,4-dideoxy-1,4-imino-D-ribitols bearing C-bonded aromatic substituents at C-1 have been synthesized, following carbanion additions to the imine 2, and tested as potential nucleoside hydrolase inhibitors. Nucleoside analogues 8, 11, 14, 17, 20, 24-26, 28 exhibit Ki values in the range 0.2-22 microM against two representative isozymes of protozoan nucleoside hydrolases.

UI MeSH Term Description Entries
D009699 N-Glycosyl Hydrolases A class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars. Glycoside Hydrolases, Nitrogen-linked,Hydrolases, N-Glycosyl,Nucleosidase,Nucleosidases,Nucleoside Hydrolase,Nitrogen-linked Glycoside Hydrolases,Nucleoside Hydrolases,Glycoside Hydrolases, Nitrogen linked,Hydrolase, Nucleoside,Hydrolases, N Glycosyl,Hydrolases, Nitrogen-linked Glycoside,Hydrolases, Nucleoside,N Glycosyl Hydrolases,Nitrogen linked Glycoside Hydrolases
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D056890 Eukaryota One of the three domains of life (the others being BACTERIA and ARCHAEA), also called Eukarya. These are organisms whose cells are enclosed in membranes and possess a nucleus. They comprise almost all multicellular and many unicellular organisms, and are traditionally divided into groups (sometimes called kingdoms) including ANIMALS; PLANTS; FUNGI; and various algae and other taxa that were previously part of the old kingdom Protista. Eukaryotes,Eucarya,Eukarya,Eukaryotas,Eukaryote

Related Publications

R H Furneaux, and V L Schramm, and P C Tyler
Binding modes for substrate and a proposed transition-state analogue of protozoan nucleoside hydrolase.
October 1995, Biochemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Phosphonamidates as transition-state analogue inhibitors of thermolysin.
September 1983, Biochemistry,
R H Furneaux, and V L Schramm, and P C Tyler
alpha-aminoaldehydes: transition state analogue inhibitors of leucine aminopeptidase.
August 1982, Biochemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Bivalent transition-state analogue inhibitors of human glyoxalase I.
December 2003, Organic letters,
R H Furneaux, and V L Schramm, and P C Tyler
Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
December 1985, Journal of medicinal chemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Potential transition state analogue inhibitors for the penicillin-binding proteins.
January 2003, Biochemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
May 2004, Bioorganic & medicinal chemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Toxicity of nucleoside-analogue reverse-transcriptase inhibitors.
March 2000, Lancet (London, England),
R H Furneaux, and V L Schramm, and P C Tyler
Nucleotide analogue inhibitors of purine nucleoside phosphorylase.
February 1990, The Journal of biological chemistry,
R H Furneaux, and V L Schramm, and P C Tyler
Computer simulations of trypanosomal nucleoside hydrolase: determination of the protonation state of the bound transition-state analogue.
July 2002, Journal of the American Chemical Society,
Copied contents to your clipboard!